Form 8-K · Current report
Prologis 8-K, filed Aug 5, 2026
- Filed
- CIK
- 0001045609
- Accession no.
- 0001104659-26-090724
Summary
Prologis entered an underwriting agreement with J.P. Morgan Securities LLC and BofA Securities, Inc. for an underwritten public offering of 15,000,000 shares of common stock expected to yield about $2.1 billion in net proceeds, or about $2.4 billion if the underwriters' 2,250,000-share over-allotment option is exercised in full, with the offering expected to close on August 5, 2026. Prologis said it intends to contribute the proceeds to its operating partnership for general corporate purposes, including funding potential acquisitions such as SEGRO plc, and that there is no assurance the SEGRO plc combination will be completed.
Key points
- The underwriting agreement, dated August 4, 2026, includes a 30-day lock-up on sales or transfers of common stock without the underwriters' written consent, subject to exceptions.
- The offering is being made under an effective shelf registration statement, a base prospectus dated August 15, 2025, and a prospectus supplement dated August 4, 2026.
- Venable LLP provided an opinion on Maryland law issues concerning the shares, filed as Exhibit 5.1.
- The filing states that Prologis intends to contribute the cash proceeds to Prologis, L.P. in exchange for operating partnership units.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01. Other Events. On August 4, 2026, Prologis, Inc. (“Prologis” or the “Company”) entered into an underwriting agreement, dated August 4, 2026, among the Company, its operating partnership, Prologis, L.P. (the “Operating Partnership”), and J.P. Morgan Securities LLC and BofA Securities, Inc., as the underwriters (the “Underwriting Agreement”) in connection with an underwritten public offering of 15,000,000 shares of its common stock, $0.01 par value per share (the “Common Stock”), resulting in net proceeds to the Company of approximately $2.1 billion (or approximately $2.4 billion if the underwriters’ option (described below) is exercised in full), in each case after deducting…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.